Incidence of seizure exacerbation and seizures reported as adverse events during adjunctive treatment with eslicarbazepine acetate: A pooled analysis of three Phase III controlled trials

OBJECTIVE: To investigate whether adjunctive eslicarbazepine acetate (ESL) could lead to exacerbation of seizures in some patients. METHODS: Post‐hoc analysis of data pooled from three Phase III trials of adjunctive ESL (studies 301, 302, and 304) for refractory partial‐onset seizures (POS). Followi...

Descripción completa

Detalles Bibliográficos
Autores principales: Carreño, Mar, Benbadis, Selim, Rocha, Francisco, Blum, David, Cheng, Hailong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Full‐length Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5862126/
https://www.ncbi.nlm.nih.gov/pubmed/29588976
http://dx.doi.org/10.1002/epi4.12083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5862126/
https://www.ncbi.nlm.nih.gov/pubmed/29588976
http://dx.doi.org/10.1002/epi4.12083

Ejemplares similares